- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Ketorolac Injection will have significant change from previous year. By the most conservative estimates of global Ketorolac Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Ketorolac Injection market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Ketorolac Injection market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Ketorolac Injection, covering the supply chain analysis, impact assessment to the Ketorolac Injection market size growth rate in several scenarios, and the measures to be undertaken by Ketorolac Injection companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
15mg/ml
30mg/ml
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinics
Recovery Center
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Almaject
Fosun Pharma
Amphastar
Hikma
Pfizer
Fresenius Kabi
Athenex
Sagent
BD RX
Alvogen
Virtus Pharmaceuticals
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Ketorolac Injection consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Ketorolac Injection market by identifying its various subsegments.
Focuses on the key global Ketorolac Injection manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Ketorolac Injection with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Ketorolac Injection submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Ketorolac Injection?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Ketorolac Injection Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ketorolac Injection Consumption 2015-2025
2.1.2 Ketorolac Injection Consumption CAGR by Region
2.2 Ketorolac Injection Segment by Type
2.2.1 15mg/ml
2.2.2 30mg/ml
2.3 Ketorolac Injection Consumption by Type
2.3.1 Global Ketorolac Injection Consumption Market Share by Type (2015-2020)
2.3.2 Global Ketorolac Injection Revenue and Market Share by Type (2015-2020)
2.3.3 Global Ketorolac Injection Sale Price by Type (2015-2020)
2.4 Ketorolac Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Recovery Center
2.5 Ketorolac Injection Consumption by Application
2.5.1 Global Ketorolac Injection Consumption Market Share by Type (2015-2020)
2.5.2 Global Ketorolac Injection Value and Market Share by Type (2015-2020)
2.5.3 Global Ketorolac Injection Sale Price by Type (2015-2020)
3 Global Ketorolac Injection by Company
3.1 Global Ketorolac Injection Sales Market Share by Company
3.1.1 Global Ketorolac Injection Sales by Company (2018-2020)
3.1.2 Global Ketorolac Injection Sales Market Share by Company (2018-2020)
3.2 Global Ketorolac Injection Revenue Market Share by Company
3.2.1 Global Ketorolac Injection Revenue by Company (2018-2020)
3.2.2 Global Ketorolac Injection Revenue Market Share by Company (2018-2020)
3.3 Global Ketorolac Injection Sale Price by Company
3.4 Global Ketorolac Injection Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Ketorolac Injection Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Ketorolac Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Ketorolac Injection by Regions
4.1 Ketorolac Injection by Regions
4.2 Americas Ketorolac Injection Consumption Growth
4.3 APAC Ketorolac Injection Consumption Growth
4.4 Europe Ketorolac Injection Consumption Growth
4.5 Middle East & Africa Ketorolac Injection Consumption Growth
5 Americas
5.1 Americas Ketorolac Injection Consumption by Countries
5.1.1 Americas Ketorolac Injection Consumption by Countries (2015-2020)
5.1.2 Americas Ketorolac Injection Value by Countries (2015-2020)
5.2 Americas Ketorolac Injection Consumption by Type
5.3 Americas Ketorolac Injection Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Ketorolac Injection Consumption by Regions
6.1.1 APAC Ketorolac Injection Consumption by Regions (2015-2020)
6.1.2 APAC Ketorolac Injection Value by Regions (2015-2020)
6.2 APAC Ketorolac Injection Consumption by Type
6.3 APAC Ketorolac Injection Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Ketorolac Injection by Countries
7.1.1 Europe Ketorolac Injection Consumption by Countries (2015-2020)
7.1.2 Europe Ketorolac Injection Value by Countries (2015-2020)
7.2 Europe Ketorolac Injection Consumption by Type
7.3 Europe Ketorolac Injection Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Ketorolac Injection by Countries
8.1.1 Middle East & Africa Ketorolac Injection Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Ketorolac Injection Value by Countries (2015-2020)
8.2 Middle East & Africa Ketorolac Injection Consumption by Type
8.3 Middle East & Africa Ketorolac Injection Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Ketorolac Injection Distributors
10.3 Ketorolac Injection Customer
11 Global Ketorolac Injection Market Forecast
11.1 Global Ketorolac Injection Consumption Forecast (2021-2025)
11.2 Global Ketorolac Injection Forecast by Regions
11.2.1 Global Ketorolac Injection Forecast by Regions (2021-2025)
11.2.2 Global Ketorolac Injection Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Ketorolac Injection Forecast by Type
11.8 Global Ketorolac Injection Forecast by Application
12 Key Players Analysis
12.1 Almaject
12.1.1 Company Information
12.1.2 Ketorolac Injection Product Offered
12.1.3 Almaject Ketorolac Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Almaject Latest Developments
12.2 Fosun Pharma
12.2.1 Company Information
12.2.2 Ketorolac Injection Product Offered
12.2.3 Fosun Pharma Ketorolac Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Fosun Pharma Latest Developments
12.3 Amphastar
12.3.1 Company Information
12.3.2 Ketorolac Injection Product Offered
12.3.3 Amphastar Ketorolac Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Amphastar Latest Developments
12.4 Hikma
12.4.1 Company Information
12.4.2 Ketorolac Injection Product Offered
12.4.3 Hikma Ketorolac Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Hikma Latest Developments
12.5 Pfizer
12.5.1 Company Information
12.5.2 Ketorolac Injection Product Offered
12.5.3 Pfizer Ketorolac Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Pfizer Latest Developments
12.6 Fresenius Kabi
12.6.1 Company Information
12.6.2 Ketorolac Injection Product Offered
12.6.3 Fresenius Kabi Ketorolac Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Fresenius Kabi Latest Developments
12.7 Athenex
12.7.1 Company Information
12.7.2 Ketorolac Injection Product Offered
12.7.3 Athenex Ketorolac Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Athenex Latest Developments
12.8 Sagent
12.8.1 Company Information
12.8.2 Ketorolac Injection Product Offered
12.8.3 Sagent Ketorolac Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Sagent Latest Developments
12.9 BD RX
12.9.1 Company Information
12.9.2 Ketorolac Injection Product Offered
12.9.3 BD RX Ketorolac Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 BD RX Latest Developments
12.10 Alvogen
12.10.1 Company Information
12.10.2 Ketorolac Injection Product Offered
12.10.3 Alvogen Ketorolac Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Alvogen Latest Developments
12.11 Virtus Pharmaceuticals
12.11.1 Company Information
12.11.2 Ketorolac Injection Product Offered
12.11.3 Virtus Pharmaceuticals Ketorolac Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Virtus Pharmaceuticals Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Ketorolac Injection Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Ketorolac Injection Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Ketorolac Injection Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of 15mg/ml
Table 7. Major Players of 30mg/ml
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Ketorolac Injection Consumption Market Share by Type (2015-2020)
Table 10. Global Ketorolac Injection Revenue by Type (2015-2020) ($ million)
Table 11. Global Ketorolac Injection Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Ketorolac Injection Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Ketorolac Injection Consumption Market Share by Application (2015-2020)
Table 15. Global Ketorolac Injection Value by Application (2015-2020)
Table 16. Global Ketorolac Injection Value Market Share by Application (2015-2020)
Table 17. Global Ketorolac Injection Sale Price by Application (2015-2020)
Table 18. Global Ketorolac Injection Sales by Company (2017-2019) (K Units)
Table 19. Global Ketorolac Injection Sales Market Share by Company (2017-2019)
Table 20. Global Ketorolac Injection Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Ketorolac Injection Revenue Market Share by Company (2017-2019)
Table 22. Global Ketorolac Injection Sale Price by Company (2017-2019)
Table 23. Global Ketorolac Injection Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Ketorolac Injection Products Offered
Table 25. Ketorolac Injection Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Ketorolac Injection Consumption by Regions 2015-2020 (K Units)
Table 27. Global Ketorolac Injection Consumption Market Share by Regions 2015-2020
Table 28. Global Ketorolac Injection Value by Regions 2015-2020 ($ Millions)
Table 29. Global Ketorolac Injection Value Market Share by Regions 2015-2020
Table 30. Americas Ketorolac Injection Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Ketorolac Injection Consumption Market Share by Countries (2015-2020)
Table 32. Americas Ketorolac Injection Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Ketorolac Injection Value Market Share by Countries (2015-2020)
Table 34. Americas Ketorolac Injection Consumption by Type (2015-2020) (K Units)
Table 35. Americas Ketorolac Injection Consumption Market Share by Type (2015-2020)
Table 36. Americas Ketorolac Injection Consumption by Application (2015-2020) (K Units)
Table 37. Americas Ketorolac Injection Consumption Market Share by Application (2015-2020)
Table 38. APAC Ketorolac Injection Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Ketorolac Injection Consumption Market Share by Countries (2015-2020)
Table 40. APAC Ketorolac Injection Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Ketorolac Injection Value Market Share by Regions (2015-2020)
Table 42. APAC Ketorolac Injection Consumption by Type (2015-2020) (K Units)
Table 43. APAC Ketorolac Injection Consumption Market Share by Type (2015-2020)
Table 44. APAC Ketorolac Injection Consumption by Application (2015-2020) (K Units)
Table 45. APAC Ketorolac Injection Consumption Market Share by Application (2015-2020)
Table 46. Europe Ketorolac Injection Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Ketorolac Injection Consumption Market Share by Countries (2015-2020)
Table 48. Europe Ketorolac Injection Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Ketorolac Injection Value Market Share by Countries (2015-2020)
Table 50. Europe Ketorolac Injection Consumption by Type (2015-2020) (K Units)
Table 51. Europe Ketorolac Injection Consumption Market Share by Type (2015-2020)
Table 52. Europe Ketorolac Injection Consumption by Application (2015-2020) (K Units)
Table 53. Europe Ketorolac Injection Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Ketorolac Injection Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Ketorolac Injection Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Ketorolac Injection Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Ketorolac Injection Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Ketorolac Injection Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Ketorolac Injection Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Ketorolac Injection Consumption by Application (2015-2020) (K Units)
Table 61. Middle East & Africa Ketorolac Injection Consumption Market Share by Application (2015-2020)
Table 62. Ketorolac Injection Distributors List
Table 63. Ketorolac Injection Customer List
Table 64. Global Ketorolac Injection Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Ketorolac Injection Consumption Market Forecast by Regions
Table 66. Global Ketorolac Injection Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Ketorolac Injection Value Market Share Forecast by Regions
Table 68. Global Ketorolac Injection Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Ketorolac Injection Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Ketorolac Injection Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Ketorolac Injection Value Market Share Forecast by Type (2021-2025)
Table 72. Global Ketorolac Injection Consumption Forecast by Application (2021-2025) (K Units)
Table 73. Global Ketorolac Injection Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Ketorolac Injection Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Ketorolac Injection Value Market Share Forecast by Application (2021-2025)
Table 76. Almaject Product Offered
Table 77. Almaject Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 78. Almaject Main Business
Table 79. Almaject Latest Developments
Table 80. Almaject Basic Information, Company Total Revenue (in $ million), Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 81. Fosun Pharma Product Offered
Table 82. Fosun Pharma Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 83. Fosun Pharma Main Business
Table 84. Fosun Pharma Latest Developments
Table 85. Fosun Pharma Basic Information, Company Total Revenue (in $ million), Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 86. Amphastar Product Offered
Table 87. Amphastar Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 88. Amphastar Main Business
Table 89. Amphastar Latest Developments
Table 90. Amphastar Basic Information, Company Total Revenue (in $ million), Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 91. Hikma Product Offered
Table 92. Hikma Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 93. Hikma Main Business
Table 94. Hikma Latest Developments
Table 95. Hikma Basic Information, Company Total Revenue (in $ million), Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 96. Pfizer Product Offered
Table 97. Pfizer Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 98. Pfizer Main Business
Table 99. Pfizer Latest Developments
Table 100. Pfizer Basic Information, Company Total Revenue (in $ million), Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 101. Fresenius Kabi Product Offered
Table 102. Fresenius Kabi Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 103. Fresenius Kabi Main Business
Table 104. Fresenius Kabi Latest Developments
Table 105. Fresenius Kabi Basic Information, Company Total Revenue (in $ million), Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 106. Athenex Product Offered
Table 107. Athenex Basic Information, Company Total Revenue (in $ million), Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Athenex Main Business
Table 109. Athenex Latest Developments
Table 110. Athenex Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. Sagent Product Offered
Table 112. Sagent Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. Sagent Main Business
Table 114. Sagent Latest Developments
Table 115. Sagent Basic Information, Company Total Revenue (in $ million), Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 116. BD RX Product Offered
Table 117. BD RX Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 118. BD RX Main Business
Table 119. BD RX Latest Developments
Table 120. BD RX Basic Information, Company Total Revenue (in $ million), Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 121. Alvogen Product Offered
Table 122. Alvogen Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 123. Alvogen Main Business
Table 124. Alvogen Latest Developments
Table 125. Alvogen Basic Information, Company Total Revenue (in $ million), Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 126. Virtus Pharmaceuticals Product Offered
Table 127. Virtus Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 128. Virtus Pharmaceuticals Main Business
Table 129. Virtus Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Virtus Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Ketorolac Injection
Figure 2. Ketorolac Injection Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Ketorolac Injection Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Ketorolac Injection Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of 15mg/ml
Figure 7. Product Picture of 30mg/ml
Figure 8. Global Ketorolac Injection Consumption Market Share by Type (2015-2020)
Figure 9. Global Ketorolac Injection Value Market Share by Type (2015-2020)
Figure 10. Ketorolac Injection Consumed in Hospital
Figure 11. Global Ketorolac Injection Market: Hospital (2015-2020) (K Units)
Figure 12. Global Ketorolac Injection Market: Hospital (2015-2020) ($ Millions)
Figure 13. Ketorolac Injection Consumed in Clinics
Figure 14. Global Ketorolac Injection Market: Clinics (2015-2020) (K Units)
Figure 15. Global Ketorolac Injection Market: Clinics (2015-2020) ($ Millions)
Figure 16. Ketorolac Injection Consumed in Recovery Center
Figure 17. Global Ketorolac Injection Market: Recovery Center (2015-2020) (K Units)
Figure 18. Global Ketorolac Injection Market: Recovery Center (2015-2020) ($ Millions)
Figure 19. Global Ketorolac Injection Consumption Market Share by Application (2015-2020)
Figure 20. Global Ketorolac Injection Value Market Share by Application (2015-2020)
Figure 21. Global Ketorolac Injection Sales Market Share by Company in 2017
Figure 22. Global Ketorolac Injection Sales Market Share by Company in 2019
Figure 23. Global Ketorolac Injection Revenue Market Share by Company in 2017
Figure 24. Global Ketorolac Injection Revenue Market Share by Company in 2019
Figure 25. Global Ketorolac Injection Sale Price by Company in 2019
Figure 26. Global Ketorolac Injection Consumption Market Share by Regions 2015-2020
Figure 27. Global Ketorolac Injection Value Market Share by Regions 2015-2020
Figure 28. Americas Ketorolac Injection Consumption 2015-2020 (K Units)
Figure 29. Americas Ketorolac Injection Value 2015-2020 ($ Millions)
Figure 30. APAC Ketorolac Injection Consumption 2015-2020 (K Units)
Figure 31. APAC Ketorolac Injection Value 2015-2020 ($ Millions)
Figure 32. Europe Ketorolac Injection Consumption 2015-2020 (K Units)
Figure 33. Europe Ketorolac Injection Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Ketorolac Injection Consumption 2015-2020 (K Units)
Figure 35. Middle East & Africa Ketorolac Injection Value 2015-2020 ($ Millions)
Figure 36. Americas Ketorolac Injection Consumption Market Share by Countries in 2019
Figure 37. Americas Ketorolac Injection Value Market Share by Countries in 2019
Figure 38. Americas Ketorolac Injection Consumption Market Share by Type in 2019
Figure 39. Americas Ketorolac Injection Consumption Market Share by Application in 2019
Figure 40. United States Ketorolac Injection Consumption Growth 2015-2020 (K Units)
Figure 41. United States Ketorolac Injection Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Ketorolac Injection Consumption Growth 2015-2020 (K Units)
Figure 43. Canada Ketorolac Injection Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Ketorolac Injection Consumption Growth 2015-2020 (K Units)
Figure 45. Mexico Ketorolac Injection Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Ketorolac Injection Consumption Market Share by Countries in 2019
Figure 47. APAC Ketorolac Injection Value Market Share by Regions in 2019
Figure 48. APAC Ketorolac Injection Consumption Market Share by Type in 2019
Figure 49. APAC Ketorolac Injection Consumption Market Share by Application in 2019
Figure 50. China Ketorolac Injection Consumption Growth 2015-2020 (K Units)
Figure 51. China Ketorolac Injection Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Ketorolac Injection Consumption Growth 2015-2020 (K Units)
Figure 53. Japan Ketorolac Injection Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Ketorolac Injection Consumption Growth 2015-2020 (K Units)
Figure 55. Korea Ketorolac Injection Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Ketorolac Injection Consumption Growth 2015-2020 (K Units)
Figure 57. Southeast Asia Ketorolac Injection Value Growth 2015-2020 ($ Millions)
Figure 58. India Ketorolac Injection Consumption Growth 2015-2020 (K Units)
Figure 59. India Ketorolac Injection Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Ketorolac Injection Consumption Growth 2015-2020 (K Units)
Figure 61. Australia Ketorolac Injection Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Ketorolac Injection Consumption Market Share by Countries in 2019
Figure 63. Europe Ketorolac Injection Value Market Share by Countries in 2019
Figure 64. Europe Ketorolac Injection Consumption Market Share by Type in 2019
Figure 65. Europe Ketorolac Injection Consumption Market Share by Application in 2019
Figure 66. Germany Ketorolac Injection Consumption Growth 2015-2020 (K Units)
Figure 67. Germany Ketorolac Injection Value Growth 2015-2020 ($ Millions)
Figure 68. France Ketorolac Injection Consumption Growth 2015-2020 (K Units)
Figure 69. France Ketorolac Injection Value Growth 2015-2020 ($ Millions)
Figure 70. UK Ketorolac Injection Consumption Growth 2015-2020 (K Units)
Figure 71. UK Ketorolac Injection Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Ketorolac Injection Consumption Growth 2015-2020 (K Units)
Figure 73. Italy Ketorolac Injection Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Ketorolac Injection Consumption Growth 2015-2020 (K Units)
Figure 75. Russia Ketorolac Injection Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Ketorolac Injection Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Ketorolac Injection Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Ketorolac Injection Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Ketorolac Injection Consumption Market Share by Application in 2019
Figure 80. Egypt Ketorolac Injection Consumption Growth 2015-2020 (K Units)
Figure 81. Egypt Ketorolac Injection Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Ketorolac Injection Consumption Growth 2015-2020 (K Units)
Figure 83. South Africa Ketorolac Injection Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Ketorolac Injection Consumption Growth 2015-2020 (K Units)
Figure 85. Israel Ketorolac Injection Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Ketorolac Injection Consumption Growth 2015-2020 (K Units)
Figure 87. Turkey Ketorolac Injection Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Ketorolac Injection Consumption Growth 2015-2020 (K Units)
Figure 89. GCC Countries Ketorolac Injection Value Growth 2015-2020 ($ Millions)
Figure 90. Global Ketorolac Injection Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 91. Global Ketorolac Injection Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 93. Americas Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 94. APAC Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 95. APAC Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 96. Europe Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 97. Europe Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 99. Middle East & Africa Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 100. United States Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 101. United States Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 102. Canada Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 103. Canada Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 104. Mexico Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 105. Mexico Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 106. Brazil Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 107. Brazil Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 108. China Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 109. China Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 110. Japan Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 111. Japan Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 112. Korea Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 113. Korea Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 115. Southeast Asia Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 116. India Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 117. India Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 118. Australia Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 119. Australia Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 120. Germany Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 121. Germany Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 122. France Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 123. France Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 124. UK Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 125. UK Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 126. Italy Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 127. Italy Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 128. Russia Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 129. Russia Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 130. Spain Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 131. Spain Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 132. Egypt Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 133. Egypt Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 134. South Africa Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 135. South Africa Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 136. Israel Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 137. Israel Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 138. Turkey Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 139. Turkey Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Ketorolac Injection Consumption 2021-2025 (K Units)
Figure 141. GCC Countries Ketorolac Injection Value 2021-2025 ($ Millions)
Figure 142. Almaject Ketorolac Injection Market Share (2018-2020)
Figure 143. Fosun Pharma Ketorolac Injection Market Share (2018-2020)
Figure 144. Amphastar Ketorolac Injection Market Share (2018-2020)
Figure 145. Hikma Ketorolac Injection Market Share (2018-2020)
Figure 146. Pfizer Ketorolac Injection Market Share (2018-2020)
Figure 147. Fresenius Kabi Ketorolac Injection Market Share (2018-2020)
Figure 148. Athenex Ketorolac Injection Market Share (2018-2020)
Figure 149. Sagent Ketorolac Injection Market Share (2018-2020)
Figure 150. BD RX Ketorolac Injection Market Share (2018-2020)
Figure 151. Alvogen Ketorolac Injection Market Share (2018-2020)
Figure 152. Virtus Pharmaceuticals Ketorolac Injection Market Share (2018-2020)
Please feel free to write an email to us or to use our electronic ticketing system.
